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Consideration of withholding or withdrawing treatment as a 
sound clinical decision developed as a consequence of the 
availability of advanced medical technology and the resultant 
ability to prolong life that in some cases is in fact unwanted 
prolongation of the dying process. This prolongation of life may 
occur without allowing for patient perspectives such as quality 
of life, being close to family members at a critical stage of life, 
and the implications of provision of end-of-life care in the alien 
environment of the hospital or intensive care unit.
Many people fear the process of dying rather than the fact 
of dying. This fear is often associated with interventions that 
may be undertaken at the end of life as well as with the knowl-
edge that suffering may be a part of dying and that both may 
be associated with loss of dignity of the individual.
The paper discusses the statement that withholding or with-
drawing treatment can be considered a sound clinical decision 
when reached in discussion with the patient (if competent), the 
family and the clinical care team. This decision is not taken 
lightly and it may not be easy to reach consensus on the deci-
sion. It is therefore important that the discussion and decision 
making are based on established bioethical principles.
In the practical setting of care for patients at the end of 
life the four principles of ethics articulated by Beauchamp and 
Childress1 are a useful guide for the clinical team.
It is important to determine the goals of care and to enter 
into the discussion with these goals in mind. Treatment should 
then be focused on achieving realistic goals of care within an 
ethical framework.
Beauchamp and Childress articulated four principles of 
bioethics: respect for autonomy, beneficence, non-maleficence 
and justice. 
Respect for autonomy addresses the concept of ‘self-rule’ 
and in particular deliberated self-rule.2 This emphasises the 
importance of patient choice and the recognition that patients 
require clear factual information in order to be able to delib-
erate on their choices. It is the responsibility of the clinician 
to ensure that s/he has the communication skills to present 
the information to the patient (and family members) in a way 
that allows for patient understanding. This is the basis of the 
concept of informed consent. Once the information has been 
presented and the patient has been encouraged to ask ques-
tions, it is still important to check the patient’s understanding, 
not simply by asking ‘Do you understand?’ but by asking ‘How 
would you explain this to …?’ This allows for identification of 
gaps in the patient’s understanding and further discussion of 
the issues.
End-of-life discussions often revolve around matters where 
there are no clear-cut answers and require the clinician to be 
comfortable in dealing with uncertainties and with compassion-
ate truth-telling. We are often then confronted with the patient’s 
question of ‘What would you do, doctor?’ and need to recog-
nise that while we may have the clinical knowledge, we do not 
have the knowledge of the patient’s life, family and priorities 
and should hesitate before giving directive advice. It may, how-
ever, be appropriate to lead the discussion, balancing benefits 
and burdens. It is important that patients are encouraged to 
take an active part in clinical decision making throughout their 
life and in every clinical encounter, as this facilitates their active 
involvement in care decisions at the end of life. It is difficult to 
devolve this responsibility to patients who have always experi-
enced autocratic medical care in previous medical encounters. 
The concept of empowerment combines autonomy and benefi-
cence and results in the patient becoming an active member 
of the management team, restoring a sense of control for the 
patient in the face of an illness that appears to have removed 
any sense of control from the patient.3
End-of-life discussions become more complex when the 
patient is no longer competent to take an active part in the 
discussion. A Living Will or Advance Directive is useful in guid-
ing the discussion but may not be comprehensively relevant 
to the circumstances under discussion. The patient may have 
identified a proxy decision maker who is now in a position of 
considerable responsibility at a time when he/she is emotion-
ally fragile. The proximity principle that those who are closest 
to the patient have the best knowledge of the patient’s wishes 
may only be true if the patient and family members have dis-
cussed these issues. Often families have delayed or avoided 
these discussions as too painful and may be uncertain or not in 
agreement as to what would be the patient’s wishes. We also 
need to recognise that people may change their minds and at-
titudes between writing the advance directive and the time for 
its implementation.4 Regular review of the advance directive is 
to be encouraged.
Beneficence refers to the ethical imperative to ensure that 
treatment benefits the patient and non-maleficence to the 
Hippocratic ideal5 of ‘first do no harm’. Taken together, the in-
tent is that treatment can only be justified if there is net benefit 
to the patient and that decisions about treatment balance ben-
efit and risk to the patient with a requirement for net benefit. In 
end-of-life care this may be a fine balance; for example, multi-
organ failure may affect metabolism and elimination of medica-
tion so that it may be difficult to predict a patient’s response to 
a particular treatment. 
It is recognised that rigorous and effective professional ed-
ucation2 based on evidence developed through research im-
proves benefit to our patients. In end-of-life care, this includes 
education and research in palliative care. 
The World Health Organization defines palliative care6 as 
‘an approach that improves the quality of life of patients and 
their families facing problems associated with life-threatening 
illness through the prevention and relief of suffering, the early 
identification and impeccable assessment and treatment of 
pain and other problems, physical, psychosocial and spiritual’. 
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Within the definition are the statements that ‘Palliative care af-
firms life and regards dying as a normal process; intends nei-
ther to hasten nor postpone death’. 
The WHO definition also states that palliative care ‘will en-
hance the quality of life, and will also positively influence the 
course of illness’.
The key is to be able to identify when active treatment will 
improve quality of life and prolong life, in contrast to when ac-
tive care and medical technology will not positively influence 
the course of the illness but merely prolong the dying process. 
Twycross makes the statement that a doctor has neither the 
right nor the duty to prescribe a lingering death.7
The fourth principle articulated by Beauchamp and Chil-
dress is that of justice. This includes distributive justice – the 
allocation of scarce resources; rights-based justice – closely 
linked to patient choice and autonomy; and legal justice – act-
ing within the laws of the country. The South African Law Com-
mission submitted a report to the Minister of Health in 1998 
which includes a recommendation to legalise withholding or 
withdrawal of life-prolonging treatment while fulfilling specific 
requirements in coming to this decision. However, this report 
has not yet received attention as yet.8  However, the Health Pro-
fessions Council of South Africa provides advice to clinicians 
in the booklet Guidelines for the Withdrawing and Withholding 
of Treatment.9 Within this booklet is the statement (7.1.2) that 
‘Health care practitioners should bear in mind that the deci-
sions of competent adult patients to refuse a particular medical 
intervention must be respected, even where this would result 
in serious harm to them or in their own death.’
Benatar et al. of the University of Cape Town Bioethics 
Centre wrote a comprehensive and considered statement on 
withholding and withdrawal of life-sustaining therapy, provid-
ing clear guidelines and recommendations and making the un-
equivocal statement that withholding or withdrawing treatment 
‘is regarded as distinct from  participating in assisted suicide or 
active euthanasia neither of which is supported by this state-
ment’.10
In the practical setting of end-of-life care, decisions are in-
fluenced by the response to treatment of the individual patient, 
and the timeline or trajectory of his illness. It is difficult to make 
decisions for patients the doctor is seeing for the first time so 
that the consideration of the trajectory of the patient’s illness 
depends on clinical notes, the patient’s and family’s narrative 
of the illness. It may be decided to embark on a course of treat-
ment with a view to evaluating the patient’s response to treat-
ment and recognising that this treatment may be withdrawn if 
it does not appear to be of benefit to the patient. The essential 
commitment is to continuity of care and non-abandonment of 
the patient during the final illness.
As discussed earlier, goals of care need to be agreed upon 
by the patient, family members and the care team and reviewed 
regularly. As an illness progresses we may find that the goals 
of care change from a goal of cure to a goal of active good 
quality of life to a goal of comfort care to a goal of dignified 
death and support for bereaved family members. The com-
plexity of end-of-life decisions demands that comprehensive 
attention be given to the particular patient and his life circum-
stances including the patient’s unique biology, the pathology of 
the illness, and the patient’s clinical condition, physical needs, 
desires, life plans, relationships, hopes, sufferings, strengths 
and limitations, perceptions and understanding of the illness.11 
Bioethical principles provide a framework within which to view 
the patient’s circumstances and to decide on an appropriate 
course of treatment. This course of treatment may change as 
the clinical condition and goals of treatment change.
Refusal of treatment
If a fully informed, competent patient refuses treatment, what 
should be our response? Are we guided by the will of the pa-
tient or the clinical condition of the patient? If we are agreed 
that the patient is competent, fully informed and not suffering 
from depression and that this is his own decision not pressu-
rised by others, we should respect our patient’s wishes even 
if this goes against our personal feelings and judgement. The 
patient requires our understanding and support of his decision. 
Family members may also require compassionate support, es-
pecially if the patient’s decision is contrary to family members’ 
wishes. In this situation, beneficence is not simply seen as clin-
ical benefit to the patient but also respecting the patient as an 
individual with benefit to the psychologically intact persona.
Futile treatment
It requires clear assessment of a patient’s condition and rec-
ognition that a treatment may be therapeutically ineffective to 
identify a point when life-prolonging treatment is no longer ap-
propriate. If medical interventions are assessed as bound to 
fail, if they will not restore a patient to independence or at least 
to an acceptable quality of life, or if they are likely to prolong 
the dying phase they may be described as futile treatments. 
There may not be agreement as to the futility or effectiveness 
of a particular treatment, and it helps to be able to distinguish 
the difference between physiological effect and benefit to the 
patient4 and again to review the goals of care for the patient at 
this new point in the disease trajectory. Uncertainties regard-
ing effectiveness of treatment arise because treatment effects 
are often expressed as percentages and it may be difficult to 
predict individual patient response.10 It may be that a treatment 
is initiated with the intent to assess the benefit for a particular 
patient and to withdraw the treatment if there is no net benefit. 
The critical discussion and decision rests on an analysis of the 
burden-benefit proportion and whether the likely benefit con-
tributes to the patient’s treatment goals. 
Advance directives and ‘do not attempt 
resuscitation’ (DNAR) orders
Advance care planning attempts to ensure that the intent of 
patient consent is respected when the patient is no longer 
able to discuss treatment options and to articulate his wishes. 
Advance directives should be discussed sensitively with pa-
tient and family members to specify what kind of treatment 
the patient would want in particular disease states. However, 
advance directives can only be a guide and cannot cover all 
eventualities. 
DNAR orders have been developed to guide health care 
workers where cardiopulmonary resuscitation is inappropri-
ate. The purpose of resuscitation is to benefit patients whose 
condition is treatable.12 In patients with incurable and terminal 
illness, resuscitation is inappropriate. The DNAR should be 
discussed with the competent patient or his proxy/close fam-
ily members, if he is not competent. The patient’s wishes are 
paramount and a Living Will or Advance Directive is helpful on 
deciding DNAR orders.
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Conclusion
When we consider the palliative care imperative to improve 
quality of life at a time when the individual is experiencing de-
clining physical function and distressing physical symptoms 
with associated psychosocial and spiritual angst, the clinician 
should have a clear understanding of bioethical principles and 
their application in the practical setting. Ten Have and Jans-
sens contend that bioethics and palliative care have similar 
objectives: ‘to maintain or reinstitute a humane medicine, … 
to commit first and foremost to the patient and their particular 
interests’.11 Decisions to withdraw or withhold treatment, when 
reached in discussion with patient, family members and the 
clinical team, uphold this essential commitment to the patient.
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